SCYNEXIS Inc (NASDAQ:SCYX)
| 2.86 Delayed Data As of Aug 05 |  +0.11 / +4.00%Today’s Change | 1.70 Today|||52-Week Range 8.10 | -53.11% Year-to-Date |
Latest SCYX News | Press Releases
No recent news for SCYNEXIS Inc.
Today’s Trading
| Previous close | 2.75 |
| Today’s open | 2.77 |
| Day’s range | 2.71 - 2.86 |
| Volume | 148,985 |
| Average volume (3 months) | 217,996 |
| Market cap | $91.5M |
Data as of 4:03pm ET, 08/05/2022
Growth & Valuation
| Earnings growth (last year) | +75.80% |
| Earnings growth (this year) | -43.68% |
| Earnings growth (next 5 years) | +256.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 12.23 |
| Price/Book | 1.96 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HOOKHOOKIPA Pharma Inc | +0.08 | +5.19% |
| SMMTSummit Therapeutics ... | -0.05 | -5.20% |
| CLSDClearside Biomedical... | +0.09 | +5.70% |
| LIFEaTyr Pharma Inc | -0.11 | -2.96% |
Data as of 4:03pm ET, 08/05/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $13.2M |
| Annual profit (last year) | -$32.9M |
| Net profit margin | -249.68% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jersey City, New Jersey |
Forecasts
